Literature DB >> 2725706

The uptake and metabolism of 3H-catecholamines in rat cerebral cortex slices.

U Trendelenburg1.   

Abstract

The accumulation and metabolism of 3H-catecholamines were studied in cerebral cortex slices obtained from rats pretreated with reserpine, during 30 min of incubation with 50 nmol/l of the 3H-amines. In some experiments neuronal uptake (uptake1) was inhibited by the presence of 0.3 mumol/l desipramine, in others COMT was inhibited by 30 mumol/l U-0521. When both MAO and COMT were intact, most of the metabolism of 3H-noradrenaline was neuronal (i.e., desipramine-sensitive). For 3H-adrenaline rates of neuronal metabolism were much lower than for 3H-noradrenaline, non-neuronal O-methylation accounting for about 50% of total metabolism. Rates of metabolism of 3H-dopamine were similar to those of 3H-noradrenaline, but with a predominance of non-neuronal metabolism, which involved O-methylation and deamination. - Under these conditions, very little 3H-catecholamine was recovered from the tissues; moreover, desipramine tended to increase tissue levels. Hence, tissue content then appears to partly reflect extracellularly distributed 3H-amines. After block of MAO rates of metabolism of 3H-noradrenaline and 3H-dopamine were greatly reduced, and tissue levels were increased. Desipramine now antagonized the accumulation of 3H-amines in the tissue, while U-0521 increased it. Rates of O-methylation (in the presence of desipramine) increased in the order 3H-noradrenaline less than 3H-dopamine. It is concluded that neuronal uptake is associated with MAO only, and rates of neuronal deamination increased in the order: 3H-adrenaline less than 3H-dopamine much less than 3H-noradrenaline.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725706     DOI: 10.1007/bf00173580

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  10 in total

1.  Occurrence and functional significance of serotonin and catecholamine uptake by astrocytes.

Authors:  H K Kimelberg
Journal:  Biochem Pharmacol       Date:  1986-07-15       Impact factor: 5.858

2.  Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.

Authors:  K H Graffe; F J Stefano; S Z Langer
Journal:  Biochem Pharmacol       Date:  1973-05-15       Impact factor: 5.858

3.  Dissociation constants and lipophilicity of catecholamines and related compounds.

Authors:  F Mack; H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-12       Impact factor: 3.000

4.  Further studies on the extraneuronal uptake and metabolism of isoprenaline in the perfused rat heart.

Authors:  H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-06       Impact factor: 3.000

5.  Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture.

Authors:  E W Pelton; H K Kimelberg; S V Shipherd; R S Bourke
Journal:  Life Sci       Date:  1981-04-06       Impact factor: 5.037

6.  The activity of the neuronal and extraneuronal catecholamine-metabolizing enzymes of the perfused rat heart.

Authors:  M Grohmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

7.  Effect of progesterone on the metabolism of noradrenaline in rabbit uterine endometrium and myometrium.

Authors:  J A Kennedy; I S de la Lande
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-08       Impact factor: 3.000

8.  The uptake and O-methylation of 3H-(+/-)-isoprenaline in rat cerebral cortex slices.

Authors:  V G Wilson; M Grohmann; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-04       Impact factor: 3.000

9.  Cocaine-sensitive O-methylation of noradrenaline in dental pulp of the rabbit: comparison with the rabbit ear artery.

Authors:  D A Parker; I S de la Lande; C Proctor; V Marino; N X Lam; I Parker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-01       Impact factor: 3.000

10.  The rate constants for the efflux of deaminated metabolites of 3H-dopamine from the perfused rat heart.

Authors:  H Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-11       Impact factor: 3.000

  10 in total
  7 in total

1.  Extracellular brain cortical levels of noradrenaline in ischemia: effects of desipramine and postischemic administration of idazoxan.

Authors:  I Gustafson; E J Westerberg; T Wieloch
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

2.  Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat.

Authors:  P T Männistö; P Tuomainen; R K Tuominen
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

3.  Contrasting effects of the imidazol(in)e alpha 2-adrenoceptor agonists, medetomidine, clonidine and UK 14,304 on extraneuronal levels of noradrenaline in the rat frontal cortex: evaluation using in vivo microdialysis and synaptosomal uptake studies.

Authors:  J W Dalley; S C Stanford
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

4.  Brain cortical tissue levels of noradrenaline and its glycol metabolites: effects of ischemia and postischemic administration of idazoxan.

Authors:  I Gustafson; A Lidén; T Wieloch
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

5.  Cannabinoid modulation of cortical adrenergic receptors and transporters.

Authors:  B A S Reyes; J C Rosario; P M T Piana; E J Van Bockstaele
Journal:  J Neurosci Res       Date:  2009-12       Impact factor: 4.164

6.  CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure.

Authors:  P C Waldmeier; P A Baumann; J J Feldtrauer; K Hauser; H Bittiger; S Bischoff; G von Sprecher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-09       Impact factor: 3.000

7.  Co-release of noradrenaline and dopamine in the cerebral cortex elicited by single train and repeated train stimulation of the locus coeruleus.

Authors:  Paola Devoto; Giovanna Flore; Pierluigi Saba; Mauro Fà; Gian Luigi Gessa
Journal:  BMC Neurosci       Date:  2005-05-02       Impact factor: 3.288

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.